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Background: The European CHOICE study was a cross-sectional survey that evaluated women’s combined
hormonal contraceptive choices before and after contraceptive counseling in Austria, Belgium, Czech Republic and
Slovakia, the Netherlands, Poland, Sweden, Switzerland, Israel, Russia, and Ukraine. The changes in method selection
before and after counseling were reported previously. In this paper we present the reasons given by the 18,787
participating women for selecting their contraceptive method of choice, as well as their perceptions about the
contraceptive pill, patch, and ring after counseling.
Methods: Women with an interest in a combined hormonal contraceptive method (pill, patch, or ring) were
counseled using a standardized counseling leaflet. The women completed questionnaires, which included
questions on why they had selected a particular method of contraception, and the extent to which they agreed
with statements about the attributes of the pill, patch, and ring. The results for each country were compared with
the percentages for all countries combined by using a binomial regression model. Multiple logistic regression
models were used to investigate the extent to which the probability of choosing a method was related to
prespecified aspects (i.e. perceptions) of each contraceptive method.
Results: ‘Easy to use’, ‘convenience’, and ‘regular menstrual bleeding’ were important selection criteria. ‘Nondaily
administration’ was one of the main reasons women selected the patch or ring. ‘Daily use’ and ‘will forget to take it’
were the primary reasons for not selecting the pill, while the main reasons for not choosing the patch included ‘not
discrete, visible’ and ‘can fall off’. In a small number of instances, the ring was rejected because some women don’t
like to use a ‘foreign body’. Women’s perceptions influenced their contraceptive decisions: positive perceptions
about a method increased the likelihood that a woman would select it. After counseling, many women associated
the pill with forgetfulness, and many still did not know about the patch or ring’s key attributes. Women’s
knowledge about a particular method was generally greater if they had chosen it.
Conclusions: To support informed contraceptive decision-making, healthcare professionals should realize that a
woman’s view of a method’s ease of use is more important than perceived efficacy, tolerability, health benefits, or risks.
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Innovation in reversible hormonal contraceptives beyond
the pill (e.g. patch, ring, implants, medicated intrauterine
system) has given couples more contraceptive choices. Al-
though women in more affluent countries generally have
access to a wide range of hormonal contraceptives, com-
bined oral contraceptives (COCs) remain the most popular
form of reversible contraception in Europe and the United
States [1-3]. Paradoxically, rates of unintended pregnancy
and abortion are still remarkably high throughout Europe.
Abortion rates (per 1000 women per year) are highest in
Sweden (22.5), the United Kingdom (22.4), Estonia (21.0),
Romania (19.5), and Hungary (18.0) [3].
Informed health care professional (HCP)–client dia-
logue and information-sharing may help women select a
contraceptive method that best suits their needs and
lifestyles, thus maximizing contraceptive compliance
and helping to prevent unintended pregnancies [4]. In
the Spanish TEAM-06 study, HCPs counseled women
about three combined hormonal contraceptive methods
(CHCs) that had similar contraceptive efficacy, safety,
and tolerability (pill, patch, and ring), but with distinctly
different routes of administration (oral, transdermal,
and vaginal) and frequency of use (daily, weekly, and
monthly) [5].
The Contraceptive Health Research of Informed Choice
Experience (CHOICE) study was modeled after the
TEAM-06 study and was designed to evaluate women’s
contraceptive choices before and after contraceptive
counseling in 11 mostly European countries [6]. In the
CHOICE study, 47% of women who had an interest in
a CHC method selected a method other than the one
they originally intended to use after receiving counsel-
ing about several CHC methods, including the pill,
patch, and ring [6]. The impact of counseling was dif-
ferent between Northern European countries and Cen-
tral and Eastern European countries, but a significant
increase in choosing the patch and ring was observed
in all countries.
All women in the CHOICE study received information
about three combined hormonal contraceptive methods
(pill, patch, and ring). We wanted to understand why
they had chosen the method they selected in preference
to the alternatives discussed. The women were asked af-
ter the counseling to indicate their reasons for selecting
their method of choice, including frequency of use, con-
venience, possibility of forgetting to take it, efficacy, cost,
tolerability, safety, familiarity, and non-contraceptive be-
nefits. They were also asked to indicate why they had
not chosen an alternative method, for example because
of efficacy or tolerability concerns, dislike of a foreign
body (ring), lack of knowledge of other users, or their
doctor had not recommended an alternative. To assess
what women knew about the various methods followingcounseling, they were asked to comment on the extent
to which they agreed, or disagreed, with eight statements
about various aspects of the pill, patch, and ring.
The primary CHOICE paper reported the changes in
method selection before and after counseling, but did not
include the data reported here. In the current paper, we
report the reasons and perceptions data for all 11 partici-
pating countries. We focus on assessing similarities and
differences between the countries, since method selection
after counseling varied so much from one country to an-
other. We also present the associations between women’s
perceptions about the pill, patch, and ring and the methods
women chose. In a third and final paper, we will assess the
extent to which the change in method selection (from the
pill to another method; or from another method to the
patch and ring) was associated with demographic and
background characteristics of the women and their health-
care professionals. Although the complete data set about
reasons and perceptions, and the associations with the
selected method, have not yet been published, some of the
data were covered in individual country publications:
Belgium (perceptions), the Czech Republic and Slovakia
(perceptions), Sweden (reasons and perceptions), and Aus-
tria (reasons and perceptions) [7-12].
Methods
The CHOICE study was a cross-sectional survey that
was carried out in eight European Union countries
(Austria, Belgium, Czech Republic and Slovakia, the
Netherlands, Poland, Sweden, and Switzerland), Israel,
the St. Petersburg and Moscow regions of the Russian
Federation (Russia), and Ukraine. The study was ini-
tiated and financed by the pharmaceutical company
MSD. The third author (JB) led a team of representa-
tives of the European Society of Contraception and
Reproductive Health (ESC) who: (i) gave expert advice
on the design and conduct of the CHOICE study; (ii)
added specific questions which were of interest to the
ESC to the protocol and the questionnaires; (iii) modi-
fied and evaluated the information leaflet about the
three contraceptive methods; (iv) developed a compre-
hensive counseling model as an educational tool to
support the study (slides and videos); and (v) guided
execution in the countries. MSD invited an expert to
join the International Steering Committee from each
of the participating countries. The International Steering
Committee (listed in the Acknowledgements) discussed
and amended the proposed project plan and question-
naires. The Steering Committee designed the counseling
leaflet (which was subsequently approved by the ESC) and
supervised execution in their country. The questionnaires
were modeled after those used in the Spanish TEAM study
and the Portuguese IMAGINE study. After input of the
ESC and the Steering Committee, the questionnaires were
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Israel, the Netherlands, Sweden, and Switzerland. This
resulted in the addition of a number of answer categories
to the questions regarding women’s choice of a particular
method.
Three questionnaires were used: a log of all women who
consulted the healthcare professional for contraception
during the study period, a questionnaire with background
characteristics of the healthcare professional, and one-per-
subject questionnaire. The third questionnaire was divided
into two parts. Part A was completed by the healthcare
professional, where he or she indicated which method of
contraception the woman contemplated prior to counsel-
ing. Part B was completed by the woman and included
questions regarding demographic characteristics and gyne-
cological information, which method the woman decided
to use after counseling, her reasons for choosing it, her rea-
sons for not choosing other methods, and her perceptions
about the pill, patch, and ring. The section on reasons for
choosing a particular method contained multiple-choice
questions, with 15–17 pre-specified answers and additional
space for the women to add their own answers. The per-
ception questions were statements with multiple-choice an-
swers: strongly agree, agree, no opinion, disagree, strongly
disagree, and do not know. Part B was designed to take ap-
proximately ten minutes to complete.
The details regarding enrollment, selection of women,
and statistical considerations are described in detail else-
where [6]. In brief, women were eligible to participate in
the CHOICE study if they were between 15 and 40 years of
age, consulted their HCP and expressed an interest in at
least one of the CHC methods (pill, patch, or ring), or con-
sidered switching from one CHC method to an alternative
one. Women who requested a contraceptive method other
than the combined pill, patch, or ring and women who ex-
cluded one of the three CHC methods were counseled in
the usual way, but they did not complete the CHOICE
questionnaire and were not considered CHOICE partici-
pants. The healthcare professionals (mostly general practi-
tioners in the Netherlands, midwives in Sweden, and
gynecologists in all other countries) used a decision flow
diagram to identify women who qualified to participate in
the study and who were invited to complete the question-
naire. This decision flow diagram has been published else-
where [6]. The majority of participating women were
counseled about the three CHC methods with assistance
of a specially designed counseling leaflet that described
the advantages and disadvantages of each method [6].
The primary objective of the CHOICE study was to
determine the selection rates of the pill, patch, and ring
with sufficient precision. The secondary objective was to
determine if the selection of a method other than the pill
(e.g. patch or ring) undergoes a statistically significant
increase after comprehensive contraceptive counseling.The primary and secondary objectives of the CHOICE
study led us to choose a target enrollment of 1500 evalu-
able questionnaires that were to be completed by women
from each participating country.
For women who chose a specific method (e.g. pill), the
percentage of women who selected this method for a par-
ticular reason was compared for each country with the
percentage for all countries combined by using a binomial
regression model. The same approach was followed for
the analysis of reasons for not choosing a method among
the group of women who selected one of the other two
CHC methods. The models were fit using the GENMOD
procedure (with binomial distribution and identity link) in
SAS 9.1 (Cary, NC, USA).
We used multiple logistic regression models to investi-
gate the extent to which the probability of choosing a
method is related to prespecified aspects (i.e. perceptions)
of each contraceptive method. We controlled for country,
a woman’s age, other relevant characteristics (e.g. edu-
cational level, employment status, plan to have [more]
children, unintended pregnancies, steady relationship, last
[main] contraceptive method), and characteristics of the
HCPs (e.g. gender, age, and most frequently recommended
contraceptive method). The data about these potential
confounders were taken from the HCP questionnaire and
Part B of the per-subject questionnaire.
The predictive factors were selected in a stepwise fashion.
Country and age of the woman (continuous variable) were
always included in the models. For the stepwise procedure,
significance levels of 0.20 and 0.05 were used for inclusion
in and exclusion from (respectively) the model. The logistic
regression models were fit using the LOGISTIC procedure
in SAS 9.1. Women with missing data were excluded.
The adequacy of the final model was assessed by check-
ing the linearity of the estimated logit on the age of women
and by the Hosmer-Lemeshow goodness-of-fit test [13].
The ability of the final model to distinguish participants
who had chosen each method (pill, patch, or ring) from
those who had not chosen a particular method was eval-
uated by the area under the receiver operating charac-
teristics curve that was captured in the c-statistic. In
general, 0.7 ≤ c < 0.8 is considered acceptable discrimina-
tion, 0.8 ≤ c < 0.9 is considered excellent discrimination,
and c ≥ 0.9 is considered outstanding discrimination [13].
Assuming asymptotic normality, the two-sided 95% Wald
confidence intervals (CIs) for the odds ratio (OR) esti-
mates were computed and are presented together with
P-values.
We expected that women who had a positive opinion
about a particular method (e.g. they agreed with its ad-
vantages and disagreed with its disadvantages) would
have a greater probability of choosing that method rela-
tive to the (reference) category of women who said ‘do
not know’ or who had ‘no opinion’ about a perception
Table 1 Demographic characteristics by country
Question All Austria Belgium Israel Netherl Sweden Switzerl CZ&SVK Poland Russia Ukraine
(N=18,787) (N=2478) (N=1801) (N=1802) (N=727) (N=1944) (N=2629) (N=1954) (N=1836) (N=1749) (N=1867)
Age, mean (SD) 25.8 (6.4) 24.9 (6.5) 27.8 (6.3) 26.7 (6.0) 24.4 (7.0) 22.6 (6.1) 23.7 (6.3) 26.6 (6.7) 26.8 (5.9) 27.3 (5.7) 27.4 (5.8)
Highest educational level, n (%)
Primary school 2163 (11.6) 396 (16.2) 34 (1.9) 51 (2.8) 87 (12.2) 195 (10.1) 1032 (39.9) 241 (12.4) 72 (3.9) 24 (1.4) 31 (1.7)
Completed high school 5565 (29.8) 832 (33.9) 581 (32.3) 612 (34.2) 339 (47.7) 1041 (53.9) 710 (27.4) 298 (15.3) 753 (41.2) 180 (10.4) 219 (11.8)
Advanced education 5192 (27.8) 728 (29.7) 826 (46.0) 469 (26.2) 225 (31.6) 198 (10.2) 472 (18.2) 1014 (52.0) 239 (13.1) 466 (26.9) 555 (29.8)
University 5724 (30.7) 495 (20.2) 355 (18.9) 660 (36.8) 60 (8.4) 498 (25.8) 374 (14.5) 397 (20.4) 762 (41.7) 1065 (61.4) 1058 (56.8)
Missing 143 27 5 10 16 12 41 4 10 14 4
Employment status, n (%)
Not employed 5614 (30.5) 846 (35.3) 518 (29.3) 410 (23.0) 169 (24.9) 901 (47.3) 726 (28.4) 592 (31.5) 582 (31.9) 414 (23.9) 456 (24.5)
Part-time employed 3619 (19.7) 452 (18.9) 263 (14.9) 531 (29.7) 316 (46.5) 506 (26.5) 509 (19.9) 184 (9.8) 256 (14.1) 262 (15.1) 340 (18.3)
Full-time employed 9147 (49.8) 1096 (45.8) 988 (55.9) 845 (47.3) 194 (28.6) 499 (26.2) 1318 (51.6) 1103 (58.7) 984 (54.0) 1054 (60.9) 1066 (57.3)
Missing 407 84 32 16 48 38 76 75 14 19 5
Do you plan to have (more) children later?
No 3420 (18.5) 351 (14.4) 479 (26.7) 214 (11.9) 110 (15.4) 192 (10.7) 259 (10.1) 503 (26.0) 475 (26.2) 340 (19.6) 497 (26.7)
Yes 11,552 (62.6) 1562 (63.9) 1027 (57.3) 1365 (76.2) 410 (57.4) 1077 (60.2) 1802 (70.0) 1172 (60.6) 1028 (56.7) 1130 (65.0) 979 (52.6)
Do not know yet 3479 (18.9) 531 (21.7) 286 (16.0) 213 (11.9) 194 (27.2) 521 (29.1%) 512 (19.9) 258 (13.3) 310 (17.1) 268 (15.4) 386 (20.7)
Missing 336 34 9 10 13 154 56 21 23 11 5
Have you had unplanned pregnancies?
No 14,848 (79.9) 2196 (89.7) 1638 (91.4) 1444 (80.6) 616 (86.5) 1528 (79.2) 2384 (91.6) 1541 (79.1) 1513 (83.1) 1041 (60.2) 947 (52.4)
Yes 3732 (20.1) 252 (10.3) 154 (8.6) 348 (19.4) 96 (13.5) 401 (20.8) 220 (8.4) 407 (20.9) 307 (16.9) 687 (39.8) 860 (47.6)
Missing 207 30 9 10 15 15 25 6 16 21 60
Have you had induced abortions?
No 13,423 (82.2) 2164 (91.9) 1603 (94.2) 1481 (84.2) 633 (90.8) 1576 (82.9) 2357 (92.5) 1623 (84.6) 0 1025 (59.9) 961 (55.1)
Yes 2914 (17.8) 191 (8.1) 99 (5.8) 277 (15.8) 64 (9.2) 325 (17.1) 192 (7.5) 296 (15.4) 1 (100) 686 (40.1) 783 (44.9)
Missing 2450 123 99 44 30 43 80 35 1835 38 123
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Table 1 Demographic characteristics by country (Continued)
Are you in a steady relationship with a partner?
No 3181 (17.0) 615 (25.0) 257 (14.3) 264 (14.8) 199 (27.9) 392 (20.3) 467 (17.9) 321 (16.5) 266 (14.5) 165 (9.5) 235 (12.6)
Yes 15,492 (83.0) 1843 (75.0) 1541 (85.7) 1522 (85.2) 513 (72.1) 1543 (79.7) 2147 (82.1) 1621 (83.5) 1566 (85.5) 1569 (90.5) 1627 (87.4)
Missing 114 20 3 16 15 9 15 12 4 15 5
Last contraceptive method (four most cited)
Combined oral contraceptive pill 7652 (41.8) 1179 (49.3) 1206 (67.4) 844 (47.9) 314 (44.7) 828 (43.5) 1245 (48.3) 795 (42.0) 697 (38.7) 175 (10.6) 369 (19.8)
Condoms 4622 (25.2) 438 (18.3) 94 (5.3) 379 (21.5) 137 (19.5) 529 (27.8) 608 (23.6) 398 (21.0) 448 (24.9) 783 (47.6) 808 (43.4)
Natural Family Planning 1010 (5.5) 49 (2.0) 11 (0.6) 45 (2.6) 5 (0.7) 9 (0.5) 37 (1.4) 100 (5.3) 61 (3.4) 419 (25.5) 274 (14.7)
I have not used contraception previously 1877 (10.2) 228 (9.5) 72 (4.0) 144 (8.2) 127 (18.1) 157 (8.3) 254 (9.9) 301 (15.9) 357 (19.8) 112 (6.8) 125 (6.7)
Country: All, all countries combined; Netherl, Netherlands; Switzerl, Switzerland; CZ&SVK, Czech & Slovak Republics.
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Figure 1 Difference in proportions between women’s selection of a contraceptive method after counseling versus before counseling
(using questionnaires where both post-counseling and pre-counseling contraceptive choices were non-missing). Pill, combined oral
contraceptive pill; patch, transdermal patch; ring, vaginal ring; other method, other contraceptive method; undecided, women did not show a
preference for the pill, patch, ring, or other method. aP < 0.001; b0.001 ≤ P < 0.01; c0.01 ≤ P < 0.05; dnot significant (P ≥ 0.05).
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versely, we expected that women who had a negative
opinion about a particular method (i.e. they disagreed
with its advantages and agreed with its disadvantages)
would have a lower probability of choosing that method
(OR < 1).
Results
The CHOICE study (began in April 2009 and ended in
October 2010) included 1730 HCPs. The HCP study logs
from nine countries (HCPs in Israel and the Netherlands
did not keep logs) indicated that 65,603 women con-
sulted their HCPs for contraception during the study pe-
riod. Of those women, 18,787 expressed an interest in
starting or switching to a new CHC method and com-
pleted Part B of the study questionnaire. The target num-
ber of participants per country was exceeded (range,
1749–2629 women/questionnaires) in all countries except
the Netherlands, where only 727 women were recruited.
The mean age (± standard deviation) of participating
women was 25.8 ± 6.4 years (Table 1).
Many characteristics, including education and full-time
employment, varied considerably between countries. Prior
to counseling, women were most likely to use COCs
(41.8%), condoms (25.2%), natural family planning (5.5%)
or no method (10.2%) (Table 1). COC and condom use
varied widely between countries. Nearly one-fifth of wo-
men had experienced either unintended pregnancy,induced abortion, or both; rates of unintended pregnancy
and induced abortion were especially high in Russia (both
40%) and Ukraine (48% and 45%, respectively) and low in
Belgium (9% and 6%, respectively) (Table 1) [6].
In the 11 countries combined, a statistically signifi-
cant increase was noted in the proportion of women
who chose the method after counseling versus those
who intended to use it before counseling for the patch
(+3.7%, 97.5% CI 3.3 to 4.2; P < 0.001; McNemar’s test)
and the ring (+21.7%, 97.5% CI 21.0 to 22.5; P < 0.001)
(Figure 1). A statistically significant decrease in pro-
portions was observed for the pill (−0.9%, 95% CI −1.7
to −0.2; P = 0.018), other combined methods (−3.1%, 95%
CI −3.6 to −2.7; P < 0.001), and for women who were
undecided regarding which method they preferred to
use (−21.4%, 95% CI −22.1 to −20.7; P < 0.001). The
difference in proportions for each individual country
was also calculated.
Reasons for choosing a method after counseling are
shown in Table 2 and Additional file 1: Table S1.
Women who chose the pill or patch after counseling
were most likely to cite ‘easy to use’ as a reason that
led to their selection. ‘Regular menstrual bleeding’ and
‘relief from menstrual pain’ were also often cited as a
reason why women chose the pill. ‘Nondaily adminis-
tration’ was the first and second most frequently given
reason for selecting the ring and patch, respectively.
‘Will not forget it’ was cited by 56.8% of women who
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patch compared with 21.7% of pill adopters. More than
half (60.5%) of women who chose the ring did so be-
cause their doctor recommended it.
Reasons for choosing a method were similar in most
countries. However, within certain countries, the most
prominent reasons varied from the percentage in all
countries combined by a statistically significant margin
(P < 0.001 for each reason listed in this paragraph). In
Ukraine, women who selected the pill were less likely to
state ‘daily use’ as one of the reasons they selected the pill.
Women in Russia and Ukraine who selected the pill were
more likely to state they chose it because it was ‘recom-
mended by my doctor’ and was a ‘well-researched method’.
If they chose the patch or ring, women in Russia and
Ukraine were more likely to state that they selected theseTable 2 Reasons women selected the daily pill, weekly
patch, or monthly ring after counseling (all countries
combined)
Reasons women selected a
particular method, n (%)
Pill Patch Ring
(n = 9418) (n = 1541) (n = 5520)
Daily use 3491 (37.1) — —
Weekly use — 1053 (68.3) —
Monthly use — — 4128 (74.8)
Will not forget it 2044 (21.7) 819 (53.1) 3135 (56.8)
Convenience 4197 (44.6) 1039 (67.4) 3361 (60.9)
Easy to use 6351 (67.4) 1165 (75.6) 3232 (58.6)
My friend uses it 2550 (27.1) 315 (20.4) 1026 (18.6)
I am used to it 3358 (35.7) 80 (5.2) 211 (3.8)
Discrete 2365 (25.1) — 1815 (32.9)
Can check it, visible — 632 (41.0) —
Recommended by my doctor 3140 (33.3) 581 (37.7) 3338 (60.5)
Low hormone levels 2024 (21.5) 498 (32.3) —
Steady, low hormone levels — — 3246 (58.8)
Well-researched method 3720 (39.5) — —
Still effective if I experience
vomiting
— 671 (43.5) 2721 (49.3)
Still effective with certain
antibiotics
— — 1776 (32.2)
Regular menstrual bleeding 6184 (65.7) 694 (45.0) 2719 (49.3)
Low chance of side effects 1881 (20.0) 570 (37.0) 2665 (48.3)
Not dangerous 1748 (18.6) 497 (32.3) 1859 (33.7)
Relief from menstrual pain 4556 (48.4) 343 (22.3) 1383 (25.1)
Relief from acne 2812 (29.9) 122 (7.9) 468 (8.5)
Other 410 (4.4) 39 (2.5) 141 (2.6)
Patch = transdermal patch; pill = combined oral daily pill; ring = vaginal ring;
‘—’ = not asked for particular method; n = number of subjects who selected
at least one of the pre-specified reasons; other = other reason not previously
specified. Missing responses (number of subjects who did not select any of
the pre-specified reasons): daily pill, n = 26; weekly patch, n = 8; monthly ring,
n = 20.methods because they were ‘not dangerous’. Conversely,
women in Belgium and the Netherlands who selected the
pill were less likely to cite ‘well-researched method’ as a
reason for choosing it. In Austria, ‘convenience’ mattered
to fewer women who selected the pill, patch, or ring. ‘Con-
venience’ also mattered to fewer women in Switzerland
who selected the patch and ring. In the Czech Republic
and Slovakia, women were more likely to cite ‘weekly use’
and ‘monthly use’ as reasons to choose the patch and ring,
respectively. In the Netherlands, women were less likely to
state they selected the patch and ring because they are
‘easy to use’. In Poland, ‘discretion’ was more frequently
given as a reason for women choosing the pill and ring rel-
ative to the percentage in all 11 countries combined.
Reasons for not choosing a method are shown in Table 3
and Additional file 2: Table S2. The top two reasons
women did not select the pill included ‘daily use’ and ‘will
forget to take it’. Women who did not select the patch
cited ‘not discrete, visible’ and ‘can fall off ’. For women
who did not select the ring, ‘don’t like to use foreign body’
and ‘more convenient methods are available’ were the
most common reasons. For 21.8% of women who did not
choose the ring, cost was a factor that led them to choose
an alternative method.
Within certain countries, many of the reasons that
women cited for not choosing the pill, patch, or ring
varied from the (pooled) response across all countries
combined by a statistically significant margin (P < 0.001
for each reason listed in this paragraph). In Belgium,
Israel, and the Netherlands, women were less likely to cite
‘daily use’ as a reason for not selecting the pill. Women in
Austria, Belgium, Israel, and the Netherlands were less
likely to cite ‘more convenient methods are available’ as
the reason they did not select the pill. In Poland, women
who did not select the ring were more likely to state
they were ‘not interested in monthly contraception’. In
Russia, women who did not select the patch were more
likely to cite that the patch ‘can irritate skin’. Women in
the Netherlands were more likely to avoid selecting the
patch because they did not know anybody else who used
it. Women in the Czech Republic/Slovakia and Ukraine
were more likely to cite cost as a reason for not choos-
ing the ring. In Russia and Ukraine, women were more
likely to state that they ‘do not like to use a foreign
body’ as a reason for not choosing the ring. In contrast,
women in Belgium, Sweden, and Switzerland were less
likely to cite ‘do not like to use a foreign body’ as the
reason for rejecting the ring. In Ukraine, women more
often stated that their partner did not like the ring.
In Table 4, women’s perceptions about the pill, patch, or
ring after counseling are shown for all countries com-
bined. While more than 90% of women strongly agreed
that the pill ‘prevents pregnancy effectively’, fewer than
75% of women strongly agreed that the patch and ring do
Table 3 Reasons not to choose the pill, patch, or ring (all countries combined)
Reasons why women who selected the: Patch or ring Pill or ring Pill or patch
Did not select the: Pilla Patchb Ringc
(%) (%) (%)
Daily use 5083 (72.0) — —
Not interested in weekly contraception — 3879 (26.0) —
Not interested in monthly contraception — — 2174 (19.8)
More convenient methods are available 3364 (47.6) 5893 (39.5) 4406 (40.2)
Not easy to use 541 (7.7) 1163 (7.8) 2766 (25.2)
Heard negative stories 1337 (18.9) 1908 (12.8) 993 (9.1)
Not effective 144 (2.0) 411 (2.8) 159 (1.5)
Will forget to take it 4788 (67.8) — —
Will forget to remove and replace — 2877 (19.3) —
Will forget to remove — — 1959 (17.9)
Do not like to detach from skin — 3851 (25.8) —
Do not like to use a foreign body — — 5308 (48.4)
No regular menstrual bleeding 339 (4.8) 486 (3.3) 436 (4.0)
Very old method 742 (10.5) — —
Cost 187 (2.6) 1957 (13.1) 2387 (21.8)
Not effective with certain antibiotics 1958 (27.7) — —
Efficacy reduced by vomiting, diarrhea 3167 (44.9) — —
Not discrete, visible — 7911 (53.0) —
Can fall off — 7228 (48.4) —
Can fall out — — 2116 (19.3)
Can irritate skin — 5817 (38.9) —
Do not know anybody who uses it 63 (0.9) 3920 (26.2) 3709 (33.8)
Doctor did not recommend it 441 (6.2) 1216 (8.1) 653 (6.0)
My partner does not like it 170 (2.4) 595 (4.0) 885 (8.1)
Side effects 2433 (34.5) 481 (3.2) 277 (2.5)
Dangerous 324 (4.6) 75 (0.5) 105 (1.0)
Other 318 (4.5) 727 (4.9) 592 (5.4)
‘—’ = reason not asked for particular method; other = other reason not previously specified.
amissing responses, n = 28; bmissing responses, n = 47; cmissing responses, n = 34.
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pill had ‘many side effects’ than the patch or ring, approxi-
mately the same percentage of women strongly disagreed
with this statement. About one quarter of women strongly
agreed that the pill ‘can be dangerous for your health’, yet
fewer than 10% of women had the same belief about the
patch and ring. More women believed the pill was ‘easy to
use’ and ‘easy to forget’ compared with the patch or ring.
Women were also more likely to associate ‘regular men-
strual bleeding’ with the pill than the patch or ring. More
than 85% of women strongly agreed that many women
use the pill, although only 15% had the same perceptions
about the patch or ring.
We also looked at these perceptions in the subset of
women who eventually selected the method concerned(Table 5). Although more women in the total sample
agreed that the pill is effective compared with those who
thought the patch or ring are effective (Table 4), the per-
centage who agreed that their selected method is effec-
tive were similar for all three methods. Women who
selected the pill after counseling were more likely to be-
lieve that it had ‘many side effects’ (25.2%) compared
with women who had chosen the patch (10.1%) or ring
(6.7%). Although 18.3% of women believed that the pill
‘can be dangerous for your health’, one in three women
who selected the pill ‘did not know’ or had ‘no opinion’
regarding its dangers. Nearly all women who chose the
pill, patch, or ring felt that their method was ‘easy to
use’. More than half of women who chose the pill agreed
that it is ‘easy to forget’; this is in contrast to the 15.3%
Table 4 Women’s perceptions about the pill, patch, and ring after counselinga
Perception statement Method Strongly agree/agree No opinion Strongly disagree/disagree Do not know Missing
n (%) n (%) n (%) n (%) (n)
Prevents pregnancy effectively Pill 17232 (93.0) 680 (3.7) 314 (1.7) 309 (1.7) 252
Patch 11809 (65.4) 2941 (16.3) 480 (2.7) 2826 (15.7) 731
Ring 13185 (73.1) 2189 (12.1) 283 (1.6) 2377 (13.2) 753
Many side effects Pill 6609 (35.7) 4699 (25.4) 6285 (34.0) 894 (4.8) 300
Patch 2580 (14.4) 6500 (36.2) 4084 (22.7) 4806 (26.7) 817
Ring 1696 (9.4) 5697 (31.7) 6061 (33.7) 4523 (25.2) 810
Can be dangerous for your health Pill 4704 (25.5) 4837 (26.2) 7620 (41.3) 1281 (6.9) 345
Patch 1694 (9.5) 5086 (28.4) 6886 (38.4) 4248 (23.7) 873
Ring 1295 (7.2) 4637 (25.8) 8100 (45.1) 3922 (21.8) 833
Easy to use Pill 14920 (81.0) 1605 (8.7) 1687 (9.2) 218 (1.2) 357
Patch 10566 (59.0) 3199 (17.9) 1813 (10.1) 2334 (13.0) 875
Ring 8445 (47.1) 3615 (20.1) 2717 (15.1) 3168 (17.7) 842
Easy to forget Pill 12034 (65.4) 2625 (14.3) 3440 (18.7) 304 (1.7) 384
Patch 4945 (27.6) 4712 (26.3) 5495 (30.7) 2766 (15.4) 869
Ring 3245 (18.2) 4428 (24.8) 7251 (40.6) 2949 (16.5) 914
Regular menstrual bleeding Pill 15845 (85.9) 1238 (6.7) 626 (3.4) 742 (4.0) 336
Patch 9240 (51.6) 3618 (20.2) 462 (2.6) 4581 (25.6) 886
Ring 10067 (56.2) 3185 (17.8) 432 (2.4) 4228 (23.6) 875
Protects against cancer Pill 5373 (29.2) 4789 (26.0) 3037 (16.5) 5228 (28.4) 360
Patch 3093 (17.3) 4956 (27.7) 2662 (14.9) 7213 (40.2) 863
Ring 3377 (18.8) 4772 (26.6) 2541 (14.2) 7252 (40.4) 845
Many women use it Pill 15816 (85.4) 1371 (7.4) 338 (1.8) 1003 (5.4) 259
Patch 2157 (12.0) 4757 (26.4) 4339 (24.1) 6737 (37.4) 797
Ring 2626 (14.6) 4713 (26.2) 3462 (19.3) 7180 (39.9) 806
aPercentage of women who strongly agreed/agreed with statement, strongly disagreed/disagreed with statement, and ‘had no opinion’ or ‘did not know’ about
statement related to the pill, patch, or ring. Data include all women (i.e. data not restricted to women who selected or did not select a particular method).
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the ring. Women believed that all three chosen methods
provided good cycle control. More than 50% of women
who chose the pill, patch, or ring ‘did not know’ or had
‘no opinion’ regarding whether the method they chose
protected against some types of cancer.
We also looked at women’s perceptions among those
who did not choose the method concerned (Table 5). This
analysis indicated that women most often agreed or
strongly agreed with the statements about the pill (e.g. the
method is effective, has ‘many side effects’, is ‘easy to use’, is
‘easy to forget’, provides regular cycle control, and is used
by many women). While women who did not choose the
patch or ring recognized that the patch and ring are effec-
tive, they often ‘did not know’ or had ‘no opinion’ about the
other statements.
In Figure 2, results are shown from the multiple lo-
gistic regression models investigating the extent to
which the probability of choosing a particular method(pill, patch, or ring) was related to women’s percep-
tions about these methods. Women who agreed or
strongly agreed that the pill is effective, ‘easy to use’,
and that ‘many women use it’ had a higher probability
(statistically significant at the 5% level) of choosing this
method compared with women who had ‘no opinion’
or ‘do not know’ (the reference category). Women who
disagreed or strongly disagreed that the pill has ‘many
side effects’ and ‘can be dangerous for your health’ had
a higher probability of choosing it compared with the
reference category. Women who agreed that the patch
is effective, ‘easy to use’, and that ‘many women use it’
or disagreed that it has ‘many side effects’ and is ‘easy
to forget’ had a significantly higher probability of
choosing it compared with women who had ‘no opin-
ion’ or ‘do not know’. Women who agreed that the ring
is effective, ‘easy to use’, allows ‘regular menstrual
bleeding’, and that ‘many women use it’ or disagreed
that it has ‘many side effects’ and is ‘easy to forget’ had
Table 5 Women’s perceptions about the pill, patch and ring after counselinga
Women who selected specified method Women who did not select specified method
Perception
statement
Method Strongly
agree/
agree n (%)
Strongly
disagree/
disagree n
(%)
No opinion/
do not know
n (%)
Missing
(n)
Method
(%)
Strongly
agree/
agree (%)
Strongly
disagree/
disagree (%)
No opinion/
do not
know (%)
Missing
(n)
Prevents
pregnancy
effectively
Pill 8969 (95.7) 92 (1.0) 309 (3.3) 74 Pill 8263 (90.2) 222 (2.4) 680 (7.4) 178
Patch 1284 (84.7) 11 (0.7) 221(14.6) 33 Patch 10525(63.6) 469 (2.8) 5546(33.5) 698
Ring 4837 (89.1) 13 (0.2) 580 (10.7) 110 Ring 8348 (66.2) 270 (2.1) 3986(31.6) 643
Many side
effects
Pill 2351 (25.2) 3941 (42.3) 3029 (32.5) 123 Pill 4258 (46.5) 2344 (25.6) 2564 (28.0) 177
Patch 151 (10.1) 649 (43.4) 696 (46.5) 53 Patch 2429 (14.7) 3435 (20.9) 10610 (64.4) 764
Ring 361 (6.7) 2861 (52.9) 2182 (40.4) 136 Ring 1335 (10.6) 3200 (25.5) 8038 (63.9) 674
Can be
dangerous for
your health
Pill 1704 (18.3) 4528 (48.7) 3073 (33.0) 139 Pill 3000 (32.8) 3092 (33.8) 3045 (33.3) 206
Patch 119 (7.9) 804 (53.7) 574 (38.3) 52 Patch 1575 (9.6) 6082 (37.0) 8760 (53.4) 821
Ring 339 (6.3) 3276 (60.7) 1785 (33.1) 140 Ring 956 (7.6) 4824 (38.4) 6774 (54.0) 693
Easy to use Pill 8627 (92.5) 214 (2.3) 489 (5.2) 114 Pill 6293 (69.2) 1473 (16.2) 1334 (14.7) 243
Patch 1318 (87.7) 34 (2.3) 151 (10.1) 46 Patch 9248 (56.4) 1779 (10.8) 5382 (32.8) 829
Ring 4188 (77.5) 149 (2.8) 1067 (19.7) 136 Ring 4257 (33.9) 2568 (20.5) 5716 (45.6) 706
Easy to forget Pill 4894 (52.7) 2457 (26.5) 1931 (20.8) 162 Pill 7140 (78.3) 983 (10.8) 998 (10.9) 222
Patch 229 (15.3) 860 (57.6) 405 (27.1) 55 Patch 4716 (28.7) 4635 (28.2) 7073 (43.1) 814
Ring 713 (13.3) 3179 (59.2) 1475 (27.5) 173 Ring 2532 (20.2) 4072 (32.6) 5902 (47.2) 741
Regular
menstrual
bleeding
Pill 8274 (88.8) 221 (2.4) 825 (8.9) 124 Pill 7571 (82.9) 405 (4.4) 1155 (12.7) 212
Patch 1063 (70.7) 31 (2.1) 410 (27.3) 45 Patch 8177 (49.9) 431 (2.6) 7789 (47.5) 841
Ring 4064 (75.5) 86 (1.6) 1233 (22.9) 157 Ring 6003 (47.9) 346 (2.8) 6180 (49.3) 718
Protects
against cancer
Pill 2686 (28.9) 1542 (16.6) 5076 (54.6) 140 Pill 2687 (29.5) 1495 (16.4) 4941 (54.2) 220
Patch 358 (23.9) 204 (13.6) 938 (62.5) 49 Patch 2735 (16.7) 2458 (15.0) 11231 (68.4) 814
Ring 1457 (27.0) 645 (11.9) 3299 (61.1) 139 Ring 1920 (15.3) 1896 (15.1) 8725 (69.6) 706
Many women
use it
Pill 8361 (89.3) 82 (0.9) 920 (9.8) 81 Pill 7455 (81.3) 256 (2.8) 1454 (15.8) 178
Patch 413 (27.4) 185 (12.3) 910 (60.3) 41 Patch 1744 (10.6) 4154 (25.2) 10584 (64.2) 756
Ring 1316 (24.4) 706 (13.1) 3379 (62.6) 139 Ring 1310 (10.4) 2756 (21.9) 8514 (67.7) 667
aPercentage of women who strongly agreed/agreed with statement, had ‘no opinion’ of statement, strongly disagreed/disagreed with statement, or ‘did not
know’ about statement related to the pill, patch, or ring. Women’s perceptions are included for those who chose and did not choose the stated method. Women
who did not choose the stated method could have chosen another method or were undecided. Data in this table are restricted to women who chose a particular
method and those who chose a method other than the listed method.
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http://www.biomedcentral.com/1472-6874/13/9a significantly higher probability of choosing the ring
compared with women who had ‘no opinion’ or ‘do not
know’. For the pill, patch, and ring, ‘easy to use’ was the
strongest distinguishing factor between adopters and
non-adopters.
Agreement or disagreement with the statements the
patch ‘can be dangerous for your health’ and enables ‘regu-
lar menstrual bleeding’ did not appear to relate to women’s
selection of the patch. In addition, agreement or disagree-
ment that the ring ‘can be dangerous for your health’ had
no relationship with selection of the ring. A woman's per-
ception of the statement ‘protects against certain forms of
cancer’ did not typically influence whether a woman chose
a method, yet women who disagreed with this statement
for the ring were less likely to choose it.Discussion
In this study, nearly half of women who underwent struc-
tured contraceptive counseling selected a CHC method
that was different from the method they originally intended
to use [6]. After informed dialogue, one in four women
who intended to use the pill selected another method
(16.4% and 65.2% of these women chose the patch and
ring, respectively) [6]. Despite these important changes,
women throughout Europe still prefer the pill, the method
with which they are most familiar. This finding has been
observed in previous reports [1,14].
Although there are many reasons why women choose
one form of contraception over another, we tried to de-
termine the most common reasons that may have influ-
enced women’s choices. Throughout Europe, ‘easy to use’
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Figure 2 Results of the multiple logistic regression analyses relating to a woman’s likelihood of choosing the pill, patch, or ring to the
perception statements about these methods. The models fit the data well (c-statistic was 0.795, 0.802, and 0.820 for the models for the pill,
patch, and ring, respectively, which was considered acceptable to excellent discrimination). The likelihood of selecting the pill, patch, or ring is
higher if the odds ratio (OR) is > 1 or lower if the OR is < 1 for women who ‘strongly agree/agree’ (or ‘strongly disagree/disagree’) compared
with women who indicated they had ‘no opinion’ or ‘do not know’ about the perception statement in relation to the method. Two-sided 95%
confidence intervals (CIs) are based on asymptotic normality of the OR estimates. The likelihood of selecting a method is higher (by a statistically
significant margin at 5% level) if the lower limit of the CI is > 1. Conversely, the likelihood of selecting a method is lower (by a statistically
significant margin at 5%) if the upper limit of the CI is < 1. If the CI contains 1, women who ‘strongly agree/agree’ (or ‘strongly disagree/disagree’)
compared with those who had ‘no opinion’ or ‘do not know’ do not differ by a statistically significant margin with respect to the probability of
choosing the method.
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‘Nondaily administration’ is important for women’s se-
lection of the patch and ring. Matters of convenience
seem to be especially important for women’s selection of
the patch or ring. Women who did not choose the pill
did so because of its daily use, the likelihood of forget-
ting it, ‘more convenient methods are available’, and be-
cause the efficacy of the pill is reduced by vomiting or
diarrhea. The patch was often not selected because it is
‘not discrete, visible’ and ‘can fall off ’. The ring was often
not selected because women ‘do not like to use a foreign
body’ and ‘more convenient methods are available’.
Knowledge of contraceptive methods obtained as a
result of counseling appeared to be a major relevant
factor. Women’s perceptions varied for each method,
yet women who did not select a specified method were
more likely to answer ‘do not know’ to a given state-
ment than women who selected a particular method. If
a woman is less knowledgeable about a method, her
HCP can help her become better informed. This obser-
vation reinforces the need for HCPs to provide
comprehensive contraceptive counseling that encour-
ages an exchange of information between HCPs andwomen. For all listed reasons, the percentage of
women who agreed with statements given to them was
consistently high for the pill.
In Central and Eastern Europe, more women switched
to the patch or ring after counseling. In these regions,
we speculate that counseling made them overcome an
initial lack of knowledge about alternatives to the pill;
they often cited ‘recommended by my doctor’ as a rea-
son for choosing the patch or ring. Indeed, other reports
already indicated that HCP preferences had a greater
influence on women’s contraceptive choices in Central
and Eastern European countries compared with Northern
European countries [6].
In Belgium and the Netherlands, women were less
likely to cite ‘well-researched method’ as the reason they
selected the pill, possibly because they believe the patch
and ring are also well-researched methods. Safety
concerns seemed to matter less in Belgium and the
Netherlands, but played more of a prominent role in
Russia and Ukraine.
The difference in the percentage of women who agreed
that the pill, patch, or ring prevents pregnancy effectively
may have been influenced by the relatively large number
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Therefore, we specifically looked at perceptions of women
who selected the method concerned. The percentages of
women who agreed that their chosen method was effec-
tive in preventing pregnancy, easy to use, and effective in
cycle regulation appeared to be similar for each method.
Surprisingly, more women who chose the pill than the
patch or ring thought the method had side effects and
could be dangerous. Protection against certain forms of
cancer was not recognized in any of the three methods. In
a study that assessed the perceptions and attitudes of
Swedish teenage girls (≤ 17 years old), many stated that
hormonal contraceptives may cause negative side effects
and damage to the body, especially during puberty [15].
The current data indicate that even women who choose
the pill may have negative perceptions about their method;
these women may have chosen the pill because of a lack
of knowledge about alternative methods.
In a recent study that surveyed women in France,
Germany, Italy, Spain, and the United Kingdom, social
and cultural differences between these countries influ-
enced women’s decisions regarding their method of
contraception [1]. Among the selected countries in the
CHOICE study, religion, socioeconomic status, and other
factors may have influenced women’s contraceptive choices.
In the Czech Republic and Slovakia, Poland, and Ukraine,
we noted that women placed more emphasis on using dis-
crete forms of contraception, including the pill and ring.
Although ‘easy to use’ and administration frequency
were rated highly as selection criteria for the pill, patch, or
ring in all countries, ‘convenience’ was cited less often by
Austrian and Swiss women who selected the patch or ring
compared with women in Poland, Russia, and Ukraine.
We speculate that longstanding use of the pill may have
contributed to a more negative image regarding the pill’s
health risks (e.g. pill scares, media reports), which could
have prompted women (even in countries where conve-
nience is less important) to seek alternative contraceptive
methods.
A recent study assessed women’s perceptions about the
safety of COCs [16]. Of 794 women who were at risk of
unintended pregnancy, 56.0% stated that COCs were med-
ically safe, 39.0% believed that COCs were unsafe, and
13.2% were not sure. The top reasons women thought
COCs were unsafe included concerns about side effects
(19.5%) and prior negative experiences with COCs
(17.0%). In the CHOICE study, women who selected the
patch or ring but not the pill were almost twice as likely
to indicate that COCs have many side effects compared
with women in the previous study [16].
In the CHOICE study, the analyses of the association
between women’s choice of method and their perceptions
were, among other factors, corrected for women’s age,
HCP's most frequently recommended method, women'slast (main) contraceptive method, as well as other factors.
These factors influenced a woman’s decision-making pro-
cess. However, we also assume that cost played a decisive
role in women’s selection of a CHC method. In most of
the 11 participating countries, the patch and ring are in-
deed considerably more expensive than generic COCs,
but in general their price is quite similar to the newer,
branded COCs. Surprisingly, only 13% and 22% of partici-
pants did not choose the patch or ring, respectively, be-
cause of cost. Nevertheless, in the Czech Republic and
Slovakia and Russia, cost was a significant deterrent that
prevented many women from selecting the ring.
Our analysis of the association between a woman’s se-
lection of the pill, patch, or ring and her perceptions about
these methods after counseling indicated that ease of use
was the most important knowledge factor. In addition,
women who chose a method had a positive impression
about the method's efficacy, tolerability, safety, and cycle
control. It was disappointing to see that, following coun-
seling, so many women still indicated that they ‘did not
know’ or had ‘no opinion’ about the advantages and disad-
vantages of the patch and ring (unless they had chosen
this method). Furthermore, most women had an opinion
(positive or negative) about the pill, irrespective of whe-
ther they had chosen it.
The CHOICE study had several limitations. First, the
study focused on women who were considering a com-
bined hormonal method – women considering other forms
of contraception or who indicated prior to the counseling
they would not consider one of the three CHC methods
did not complete the questionnaires and were counseled in
the usual way. This was a deliberate decision, in consulta-
tion with the ESC, since we wanted to assess to what extent
women consider alternatives to the method they were con-
templating, provided it was a viable alternative for them.
Nevertheless, this focus limits the generalizability of the
findings only to women in the same situation. Secondly, we
did not assess contraceptive compliance, discontinuation
rates, or user satisfaction. This would have necessitated the
need for a follow-up visit, which would have been costly
and was not the primary interest of the program. Further-
more, in Belgium, Russia, and Ukraine, HCP’s favorable at-
titudes towards the patch and ring may have influenced the
information and advice they provided, leading to a greater
proportion of women who selected the patch or ring [6].
The questionnaire may have had limitations in that women
could not find the answer they wished to select. After pilot-
testing in a number of countries, we included more answer
categories to the questions relating to method of choice
over other methods, while leaving space for women to pro-
vide their own responses. It was reassuring to see that only
4-5% of participants used this space (summarized as ‘other’
in Tables 1 and 2). Finally, because of slow enrollment, we
did not meet our target enrollment of 1500 women in the
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mated selection rates of the pill, patch, and ring in that
country. We attribute low enrollment to the fact that in the
Netherlands, general practitioners saw far fewer women per
week for contraceptive advice than HCPs in other
countries.
The results from the CHOICE study allow us to draw
several conclusions. Informed dialogue between HCPs
and women encourages women to select alternative
contraceptive methods. The majority of women who
selected the pill, patch, or ring stated that daily,
weekly, or monthly use was an important consideration
that factored into their final choice. ‘Daily use’ was the
main reason why women who selected the patch or
ring did not select the pill. ‘Easy to use’ was the most
significant factor affecting women’s choices. Reasons
beyond frequency of administration, including visibil-
ity of the method (e.g. patch), placement of foreign
body inside the body (e.g. ring), and use of a well-
known method versus use of a new, more innovative
method, were important and varied significantly be-
tween countries. Additional knowledge of the various
methods following counseling also played an important
role. Surprisingly, a woman’s negative feelings about a par-
ticular method, especially the pill, did not always dissuade
her from selecting it. In Central and Eastern Europe,
women’s contraceptive decisions were more driven by
safety concerns and HCP recommendations, whereas in
Western Europe, women’s decisions were more driven by a
less favorable opinion about the pill. While patch and ring
use increased in all countries after counseling, women’s rea-
sons for selecting or not selecting a particular method var-
ied considerably between countries.
Conclusions
In conclusion, we suggest that the results of our study
demonstrate that awareness of the decision-making
factors that affect women’s choices regarding methods
of contraception may enable HCPs to make more in-
formed recommendations that are targeted to the
needs of each of their female patients.Additional files
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